This is Photoshop's version of Lorem Ipsum. Proin gravida nibh vel velit auctor aliquet.
Insight at the Speed of Light
in suspension-cell analysis platforms for immunology and immuno-oncology profiling, antibody discovery, and screening of immune targets in drug discovery and translational research.
Making flow based analysis faster, easier and more robust is just plain smart!
IntelliCyt has created the iQue Screener with this in mind.
The smartest way to answer your pressing biological questions combines getting the most insight from fewer cells in the lease amount of time. We call it the Intellicyt Advantage.
Special Announcement
Come visit us at booth #941 at SLAS in San Diego, CA January 25 – 27, 2015!
Working at Intellicyt
Compelling Headline Goes Here Talking About Working With Intellicyt.
Latest Announcements
25
Dec
News
Intellicyt Corporation Completes $7.4 Million in New Financing
IntelliCct Corporation (IntelliCyt), a leading provider of integrated platforms to accelerate drug discovery, antibody discovery and immunology...
25
Dec
News
Intellicyt Corporation Completes $7.4 Million in New Financing
Intellicyt Corporation (Intellicyt), a leading provider of integrated platforms to accelerate drug discovery, antibody discovery and immunology...